MaxCyte, (id:7983 MXCT)
3.45 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/22/2024 7:38:23 AM)
Exchange closed, opens in 1 hour 51 minutes
About MaxCyte,
Market Capitalization 374.46M
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
| Headquarters (address) |
9713 Key West Avenue Rockville 20850 MD United States |
| Phone | 301 944 1700 |
| Website | https://www.maxcyte.com |
| Employees | 143 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | MXCT |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 3.16 - 5.54 |
| Market Capitalization | 374.46M |
| P/E trailing | -9.43 |
| P/E forward | -9.10 |
| Price/Sale | 8.21 |
| Price/Book | 1.75 |
| Beta | 1.16 |
| EPS | -0.340 |
| EPS United States (ID:6, base:3395) | 24.30 |